Q2 2025 · 13F-HR
Artia Global Partners LPholdings as filed
Filed 2025-08-14 · accession 0001937964-25-000006
$415.6M
Reported value
37
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 925050106 | VRNA | VERONA PHARMA PLC | $87.4M | 21.0% | 924,204 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $75.8M | 18.2% | 752,712 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $43.2M | 10.4% | 78,311 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $41.4M | 9.97% | 494,424 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $23.9M | 5.76% | 30,700 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $16.7M | 4.01% | 155,200 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $15.6M | 3.76% | 296,750 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $14.7M | 3.53% | 81,717 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $13.3M | 3.21% | 190,752 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $8.7M | 2.09% | 91,800 | PUT | SOLE |
| 78464A870 | XBI | SPDR SER TR | $8.3M | 2.00% | 100,000 | PUT | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $7.2M | 1.73% | 1,311,840 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $6.8M | 1.65% | 20,970 | Common | SOLE |
| 74347W601 | UGL | PROSHARES TR II | $5.8M | 1.40% | 168,000 | CALL | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $5.6M | 1.35% | 10,671 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $4.5M | 1.08% | 126,285 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.0M | 0.97% | 40,000 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.8M | 0.92% | 104,190 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.0M | 0.72% | 63,930 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.0M | 0.72% | 316,700 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $2.7M | 0.65% | 14,500 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.6M | 0.62% | 96,479 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.1M | 0.51% | 12,240 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.0M | 0.47% | 54,515 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $2.0M | 0.47% | 4,400 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $1.5M | 0.37% | 41,830 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $1.4M | 0.35% | 5,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.3M | 0.31% | 475,361 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.3M | 0.31% | 22,951 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.3M | 0.30% | 40,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $1.1M | 0.27% | 80,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $982,640 | 0.24% | 34,600 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $807,964 | 0.19% | 29,200 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $556,083 | 0.13% | 41,100 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $494,747 | 0.12% | 27,319 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $462,000 | 0.11% | 20,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $457,320 | 0.11% | 30,900 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.